Amy McLemore
H Lee Moffitt Cancer Center and Research Institute
7 papers found
Refreshing results…
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes
Download from doi.orgTP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype
UploadMissing publications? Search for publications with a matching author name.